Catabasis Pharmaceuticals announces preliminary Phase 1 data for hypercholesterolaemia product candidate CAT-2054
4 June 2015 | By Victoria White
Catabasis has announced preliminary Phase 1 clinical trial data for CAT-2054 - its candidate for the potential treatment of hypercholesterolaemia...